Literature DB >> 9502785

Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heart.

J M Hare1, B Kim, N A Flavahan, K M Ricker, X Peng, L Colman, R G Weiss, D A Kass.   

Abstract

Inhibitory G protein activity (Gi) and nitric oxide (NO) modulate muscarinic-cholinergic (MC) inhibition of cardiac beta-adrenergic inotropic responses. We hypothesized that Gi mediates MC-NO synthase (NOS) signal transduction. Isoproterenol (0.2-0.8 microg/min) and acetylcholine (1 microM) were administered to isolated perfused rat hearts pretreated with saline (controls; n = 8) or pertussis toxin (PT; 30 microg/kg intraperitoneally 3 d before study; n = 20). PT abrogated in vitro ADP-ribosylation of Gi protein alpha subunit(s) indicating near-total decrease in Gi protein function. Isoproterenol increased peak +dP/dt in both control (peak isoproterenol effect: +2, 589+/-293 mmHg/s, P < 0.0001) and PT hearts (+3,879+/-474 mmHg/s, P < 0.0001). Acetylcholine reversed isoproterenol inotropy in controls (108+/-21% reduction of +dP/dt response, P = 0.001), but had no effect in PT hearts. In controls, NG-monomethyl-L-arginine (100 microM) reduced basal +dP/dt, augmented isoproterenol +dP/dt (peak effect: +4,634+/-690 mmHg/s, P < 0.0001), and reduced the MC inhibitory effect to 69+/-8% (P < 0.03 vs. baseline). L-arginine (100 M) had no effect in controls but in PT hearts decreased basal +dP/dt by 1, 426+/-456 mmHg/s (P < 0.005), downward-shifted the isoproterenol concentration-effect curve, and produced a small MC inhibitory effect (27+/-4% reduction, P < 0.05). This enhanced response to NO substrate was associated with increased NOS III protein abundance, and a three- to fivefold increase in in vitro calcium-dependent NOS activity. Neomycin (1 microM) inhibition of phospholipase C did not reverse L-arginine enhancement of MC inhibitory effects. These data support a primary role for Gi in MC receptor signal transduction with NOS in rat heart, and demonstrate regulatory linkage between Gi and NOS III protein levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9502785      PMCID: PMC508698          DOI: 10.1172/JCI1012

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Interaction between cyclic adenosine monophosphate and cyclic gunaosine monophosphate in guinea pig ventricular myocardium.

Authors:  A M Watanabe; H R Besch
Journal:  Circ Res       Date:  1975-09       Impact factor: 17.367

2.  Pertussis toxin inhibits negative inotropic and negative chronotropic muscarinic cholinergic effects on the heart.

Authors:  S Tucek; V Dolezal; J Folbergrová; S Hynie; F Kolár; B Ostádal
Journal:  Pflugers Arch       Date:  1987-02       Impact factor: 3.657

3.  Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells.

Authors:  H C Hartzell; R Fischmeister
Journal:  Nature       Date:  1986 Sep 18-24       Impact factor: 49.962

4.  Effect of pertussis toxin on the heart muscarinic-cholinergic receptors and their function.

Authors:  J L Boyer; M Martínez-Cárcamo; A Monroy-Sánchez; J Juárez-Ayala; G Pastelín; C Posadas; J A García-Sáinz
Journal:  Life Sci       Date:  1986-08-18       Impact factor: 5.037

5.  Effect of dibutyryl cyclic GMP on cultured beating rat heart cells.

Authors:  E G Krause; W Halle; A Wollenberger
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

6.  Some statistical methods useful in circulation research.

Authors:  S Wallenstein; C L Zucker; J L Fleiss
Journal:  Circ Res       Date:  1980-07       Impact factor: 17.367

7.  Pertussis toxin-treated dog: a whole animal model of impaired inhibitory regulation of adenylate cyclase.

Authors:  J W Fleming; T D Hodges; A M Watanabe
Journal:  Circ Res       Date:  1988-05       Impact factor: 17.367

8.  Role of guanine nucleotide binding protein in the activation of polyphosphoinositide phosphodiesterase.

Authors:  S Cockcroft; B D Gomperts
Journal:  Nature       Date:  1985 Apr 11-17       Impact factor: 49.962

9.  Elevation of guanosine 3',5'-cyclic phosphate in rat heart after perfusion with acetylcholine.

Authors:  W J George; J B Polson; A G O'Toole; N D Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

10.  Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium.

Authors:  S R Kapadia; H Oral; J Lee; M Nakano; G E Taffet; D L Mann
Journal:  Circ Res       Date:  1997-08       Impact factor: 17.367

View more
  6 in total

1.  beta(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility.

Authors:  P Varghese; R W Harrison; R A Lofthouse; D Georgakopoulos; D E Berkowitz; J M Hare
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

2.  Moving into a new neighborhood: NOS goes nuclear.

Authors:  Mark T Ziolo; Brandon J Biesiadecki
Journal:  J Mol Cell Cardiol       Date:  2013-06-22       Impact factor: 5.000

Review 3.  The emerging role for type 5 phosphodiesterase inhibition in heart failure.

Authors:  Gregory D Lewis; Marc J Semigran
Journal:  Curr Heart Fail Rep       Date:  2006-09

4.  Cerebrovascular Gi Proteins Protect Against Brain Hypoperfusion and Collateral Failure in Cerebral Ischemia.

Authors:  Salvador Castaneda-Vega; Sandra Beer-Hammer; Veronika Leiss; Hanna Napieczyńska; Marta Vuozzo; Andreas M Schmid; Hang Zeng; Yi He; Ursula Kohlhofer; Irene Gonzalez-Menendez; Leticia Quintanilla-Martinez; Johann-Martin Hempel; Maik Gollasch; Xin Yu; Bernd J Pichler; Bernd Nürnberg
Journal:  Mol Imaging Biol       Date:  2022-09-08       Impact factor: 3.484

5.  Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice.

Authors:  P Jumrussirikul; J Dinerman; T M Dawson; V L Dawson; U Ekelund; D Georgakopoulos; L P Schramm; H Calkins; S H Snyder; J M Hare; R D Berger
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

Review 6.  Role of nitric oxide in the pathophysiology of heart failure.

Authors:  Hunter C Champion; Michel W Skaf; Joshua M Hare
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.